Herpes simplex viruses (HSV) are difficult to sequence due to their large DNA genome, 25 high GC content, and the presence of repeats. To date, most HSV genomes have been 26 recovered from culture isolates, raising concern that these genomes may not accurately 27 represent circulating clinical strains. We report the development and validation of a DNA Herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2) are 61 alphaherpesviruses causing over 4 billion human infections that can manifest as oral and 62 genital ulcerations, neonatal disease, herpetic keratitis, and encephalitis (1, 2). While
Introduction significant enrichment across the HSV-2 genome ( Figure 1D ).
139
Development of a custom pipeline for HSV assembly and annotation 140
We developed a computational pipeline ( Figure 2) to rapidly extract and annotate 141 near-full length HSV genomes from raw Illumina sequencing reads. By employing a 142 combination of reference-guided and assembly-based methods to construct consensus 143 sequences, we were able to recover up to 99% of the genome.
144
The workflow starts with quality analysis of raw reads followed by trimming to 145 remove adapters and low-quality regions. For samples sequenced without target capture 146 enrichment or with a low percentage of HSV reads, a k-mer based filtering method is 147 used to enrich for HSV reads based on similarity to the HSV-1 strain 17 and HSV-2 148 strain HG52 and SD90e reference sequences ( Figure 2 ). The removal of off-target reads 149 significantly speeds up downstream processing steps by preventing de novo assembly 150 of mammalian genomes. Preprocessed reads are de novo assembled into contigs and 151 the reference sequence is used to order these contigs and fill in any gaps. Reads are 152 then mapped to this resulting template and custom scripts are used to construct the final 153 consensus sequence. Finally, the consensus sequence is annotated and prepared for 154 Genbank deposit. Our pipeline combines several previously published open-source tools 155 with custom scripts and can be run on desktop computers, servers and high-throughput 156 computing clusters. On average, a single sample containing about 700,000 raw reads from our capture sequencing method for eight strains of HSV-1 and eight strains of HSV-163 2 ( Figure S2 ). For Sanger sequencing, UL23 was PCR amplified from genomic DNA 164 and Sanger sequenced to a minimum of 2X coverage. For the WGS genes, majority 165 consensus sequence for the UL23 CDS was extracted from the annotated assembly and 166 aligned against the corresponding Sanger sequence. No consensus variants were 167 recovered from either of the two genes in either HSV-1 or HSV-2, yielding an accuracy 168 of 100%.
170
Limits of genome recovery 171
To determine the lower limit of capture for our whole genome sequencing method 172 and to understand the determinants of our on-target percentage and coverage statistics,
173
we performed capture sequencing on HSV-1 and HSV-2 clinical samples across a range 174 of concentrations ( Figure 3 , Table S1 ). We calculated the pre-capture ratio of HSV 175 mass to human DNA mass based on the quantities of HSV and beta-globin recovered in 176 the initial qPCR reaction. We then compared the pre-capture HSV mass ratio to the on-177 target fraction of HSV reads after the capture as a proxy for genome recovery.
178
We find on average 10,000X enrichment of viral sequences with our capture 179 panels with a maximum of 100,000X ( Figure 3 ). With this approach we have recovered 180 whole genomes from HSV-1/2 samples with viral loads lower than 10 2 copies/rxn. Using 181 an arbitrary cut-off of 5% on-target fraction of post-capture HSV reads, we can recover 182 genomes from pre-capture ratios of 10 -7.40 for HSV-1 and 10 -5.78 for HSV-2, 183 corresponding to approximately 10 3 copies/mL for HSV-1 and 10 4 copies/mL for HSV-2.
184
Based on these copy numbers, we calculate that with capture sequencing we will be 185 able to recover whole HSV genomes directly from nearly all swabs obtained by our (Table S2 ). All
197
HSV-1 isolates were in culture for fewer than 7 days (range of 2-7 days) and only one 198 isolate (sample G9) was passaged after isolation.
199
We sequenced these samples to a median of 547,494 reads (IQR 352,038- 
204
HSV-1 UL and US sequences recovered directly from clinical specimens were 205 nearly identical to those recovered after isolation from human fibroblasts ( Figure 4 ).
206
Allowing for all mutations, UL-US culture pairs had on average 20 SNVs (range 2-59),
207
and most of these were present in repetitive elements in genes US12 and US5 that likely 208 represent sequencing/assembly artifacts. After accounting for missing data (N's), 209 homopolymers (>8 nucleotides), and sequencing/assembly artifacts due to difficult loci 210 such as high GC repeats in UL36, US5, and US12 genes, 14 of the 17 pairs of 211 specimens were entirely identical in the UL-US region. One verified mutation was 212 recovered in sample pair H5, with a synonymous C->T mutation in the consensus sequence at nucleotide 603 in UL39. The original H5 sample had a 55% C, 45% T allele 214 frequency at the locus, while the culture sample was 4% C, 96% T.
215
Sample G10 had four mutations between culture and clinical sample, including 216 three synonymous changes in UL6, UL37, and UL54 and a T207A non-synonymous 217 mutation in US7 coding sequence. All four mutations in G10 and the single mutation in 218 H5 were confirmed by Sanger sequencing of the paired culture and original samples.
219
The original sample for G10 had a notably low level of HSV-1 (18 copies/uL DNA or 220 9,000 copies/mL) and its assembly was 9.1% missing data (N's). There was no 221 evidence of HSV-2 recombination in the 17 pairs of HSV-1 sequences.
223
Detection of HSV-1 superinfection 224 Samples pairs H4 and I5 were collected from the same patient in his 50s who 225 underwent two allogeneic hematopoietic cell transplants for acute myelogenous 226 leukemia. The first sample (H4, "day 1") was collected from a tongue ulcer and the 227 second sample (I5, "day 18") was taken from an oral swab of a new tongue lesion 18 228 days later. He started foscarnet induction therapy 4 days prior to the first sample for 229 treatment of CMV reactivation, but was not treated with acyclovir in the intervening 230 period. The day 1 oral swab measured 10 5.9 copies/mL for HSV-1 while the day 18 oral 231 swab measured 10 5.4 copies/mL.
232
After removing SNVs associated with the UL36 gene, the consensus UL 233 sequences recovered from the two original oral swabs differed by 207 nucleotides, which 234 is consistent with previous estimates of average pairwise SNV differences between two 235 unrelated HSV strains (6, 9) . The consensus UL sequence from the day 1 original 236 sample and culture specimen differed at only 3 nucleotides, which were all associated 237 with homopolymers, consistent with the lack of evolution seen during culture isolation for 238 thirteen other paired HSV-1 specimens. However, the consensus UL sequence from the day 18 original sample and culture differed by 91 nucleotides, illustrating a rate of 240 change significantly higher than seen in other paired specimens.
241
We hypothesized that changes in variant frequency between two different viral 242 populations present in the day 18 specimen accounted for the increased rate of change 
251
Since the patient's HSV-1 emerged during foscarnet therapy, we next 252 interrogated our sequence data for whether antiviral resistance was present in either of 253 the oral swabs. Four non-synonymous mutations were present in the UL30 gene from 254 the day 18 oral swab compared to the day 1 oral swab at varying allele frequencies 255 (S724N, 6%; E798K, 11%; I810L, 16%; F918L, 57%). Compared to the HSV-1 17 strain 256 reference genome (NC_001806), both original samples had consensus UL30 coding 257 changes at S33G, V905M, P920S, P1199Q, and T1208A. None of these changes has 258 previously been reported to be associated with foscarnet resistance (27-29). These 259 results are consistent with the patient being superinfected with two separate HSV-1 260 strains that reactivated at separate times on the patient's tongue and were 261 simultaneously detected from the day 18 specimen. These data also indicate that in the 262 setting of superinfection, cultured samples may appear very different from swab samples 263 due to differential abilities of the multiple viruses to grow in culture.
265

Discussion
266
We report the validation of capture sequencing panels for obtaining near 267 complete HSV-1 and HSV-2 genomes directly from clinical samples. The panels allow 268 the recovery of HSV-1 and HSV-2 genomes in approximately 3-5 days with as few as 269 100,000 paired-end reads at viral concentrations that are up to 100,000-fold lower than 270 previously reported for herpes simplex viruses. The level of enrichment seen here is 271 similar to seen by others using capture panels (30, 31) . We used this panel to show that 
275
To date, direct-from-sample whole genome sequencing for herpes simplex 276 viruses has been limited to samples with extraordinarily high viral copy numbers (9).
277
The vast majority of genome sequence data available from herpes simplex viruses 278 comes from culture isolates. Our data indicate that these culture isolate sequences 
295
We also use direct from sample sequencing to show the first case of HSV-1 296 superinfection detected directly from a patient by next-generation sequencing. The 297 prevalence of HSV-1 infected individuals that carry more than one HSV-1 strain is not 298 known, while HSV-2 superinfection is estimated to occur in approximately 3.5% of 299 patients positive for HSV-2 (10). Despite HSV-1 reactivating in this patient in the setting 300 of foscarnet treatment, no previously characterized mutations for foscarnet resistance 301 were discovered (27, 29, 32) . These data underscore the current challenge in 302 confidently assigning antiviral resistance for HSV through genomic sequence.
303
Limitations of our study include examining HSV-1 evolution in the context of brief 304 culture exposure with minimal passage. Our results may not be reflective for strains that 305 undergo more passages than the initial viral isolation ("zero passage") that was 306 performed here. Notably, we and others have also not solved the problem of the high 307 degree of homopolymers and repetitive sequence in the setting of high GC content in 308 human herpes simplex viruses. Indeed, several of the loci cannot be confidently 309 synthesized as oligonucleotides for the affinity purification panel. We also limited our 310 sequence analysis to the UL and US regions of the genome.
311
In summary, we demonstrate the validation of a new robust, accurate, and 312 sensitive tool to recover near complete HSV-1 and HSV-2 genome sequences, along 313 with an easy pooling scheme to reduce overall sequencing costs. We show that HSV-1 314 culture isolates undergo very few genomic changes in the UL-US region during isolation 315 in culture. Indeed, culture may be the ultimate viral enrichment method for HSV-1 and 316 HSV-2.
Materials and Methods
319
Clinical Samples 320 HSV-1 and HSV-2 samples were selected from natural history research studies 321 at the University of Washington Virology Clinic that spanned a range of pre-capture viral 322 concentrations (Table S1 ). Excess HSV-1 samples sent to the University of Washington
323
Clinical Virology Lab for culture over a one-month period in 2017 were also selected for 324 sequencing (Table S2) Prior to capture, libraries were pooled in sets of 4-10 libraries based on the ratio 370 of HSV-1/2 to beta-globin and total number of HSV-1/2 copies present in each library. A 371 total of 300-500ng DNA is targeted for each pool. We aim for less than 10-fold variance 372 from the highest to lowest concentration in HSV-1/2 copies within each pool.
373
Hybridization capture is performed according to the IDT xGen protocol (version 2).
374
Capture panels were designed as 1X tiling 120-bp panels according to HSV-1 strain 17 375 and HSV-2 HG52 reference sequences (NC_001806, NC_001798) with human masking 
424
To confirm subtype of isolate, MRHF cells were scrapped and spotted onto welled 425 slides, air-dried, fixed in acetone and stained with monoclonal antibody to HSV-1 and 
623
Despite an average coverage of 179X, only 58% of the HSV-1 UL region had depth >= 624 10X. Y-axis denotes read depth, while X-axis is the genome position for HSV-1. HSV-1 625 genes are denoted in green while repeat regions are highlighted in light blue. B) HSV-1 626 UL locus depth correlates with pairwise identity to HSV-2 UL sequence. We calculated 627 the pairwise HSV-1 versus HSV-2 sequence identity across a 120 nucleotide sliding 628 window and plotted as a histogram (blue). For each 120 nucleotide bin across the HSV- Oral Lesion 10 -5 10 -4 10 -3 10 -2 10 -1 10 0 10 1 0% 25% 50% 75% 100% 10 -5 10 -4 10 -3 10 -2 10 -1 10 0 Precapture % HSV−2 (Total DNA) Sample Type
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